Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLoose stools and diarrhoea are among the most commonly reported side effects when reaching the Wegovy 2.4mg maintenance dose. For most people they are short-lived, arriving in the first week or two after the dose increase and then settling — but knowing what to expect, and spotting the signs that need attention, makes the difference between riding it out safely and missing something that warrants medical help. Semaglutide (Wegovy) is a prescription-only medicine; your prescriber weighs up this side-effect profile alongside your full health picture before deciding whether 2.4mg is right for you. If you are already on treatment and have questions about how diarrhoea on Wegovy 2.4mg is affecting you, this page covers the practical decision-points — when to watch and wait, when to act, and when to call for help.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide slows the rate at which the stomach empties and changes how the gut processes food. Both effects can disturb normal bowel patterns, particularly when the dose is increased. Reaching 2.4mg is the final step in a titration that has taken months, and it represents the highest concentration of semaglutide the gut has encountered. That novelty is precisely why GI symptoms (including loose stools) often flare at this point even in people who managed earlier doses without trouble.
The full Wegovy dose ladder is designed to give the body time to adapt at each level, and most people who experience diarrhoea at 2.4mg find it eases within one to two weeks as the gut adjusts. That said, the 2.4mg step tends to produce stronger effects than the earlier 1.7mg step for some; if you moved up recently, it is worth giving your system a fair settling period before concluding this dose will always feel this way.
Meal timing and composition can also influence things. Fatty or very rich meals appear to worsen GI symptoms on semaglutide for many people. Smaller portions, eaten more slowly, tend to be easier to manage, something our prescribers discuss as part of ongoing aftercare, and a point covered in more detail on our Wegovy treatment overview.
This is the core question once diarrhoea starts. The answer depends on three things: severity, duration, and what else is going on alongside it.
Mild to moderate loose stools, starting within a day or two of the 2.4mg injection and gradually improving over the following week, sit within the expected pattern described on the NHS semaglutide medicines page. Staying well hydrated (water, dilute squash, or oral rehydration solution if output is significant) is the practical priority. A quick check you can do right now: look at your urine colour. Pale straw means you are keeping up with fluid loss; anything darker than apple juice suggests you need to drink more, or seek advice.
Diarrhoea that is very frequent, watery, or accompanied by cramping and is not improving after about two weeks warrants a conversation with your prescriber. The same applies if it begins or worsens unexpectedly between doses, rather than in the days immediately following an injection. These patterns do not automatically mean something serious is wrong, but they do need a professional eye on them rather than self-management at home.
You can find a comparison of what diarrhoea typically looks like at lower doses on our pages covering the 1mg dose experience and the 1.7mg step, which may help you judge whether 2.4mg is genuinely different for you.
Most diarrhoea on Wegovy 2.4mg does not require emergency attention. These situations do:
Severe, persistent stomach pain (particularly pain that travels through to the back, with or without vomiting) should prompt urgent medical assessment. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; the combination of intense abdominal pain and GI disturbance is the symptom pattern that matters.
Signs of significant dehydration (dizziness on standing, confusion, passing very little or no urine, or a fast heartbeat) also need same-day medical attention. Dehydration from diarrhoea can stress the kidneys, and for people taking other medicines this interaction matters.
Blood in stools, a high temperature alongside diarrhoea, or any symptom that feels out of proportion to what you experienced at lower doses are all reasons to contact your GP or call 111 rather than waiting. If you are a nume patient with a concern between doses, our aftercare team is available seven days a week, see our contact page for the fastest route to us.
Any suspected side effect can also be reported directly to the MHRA via the Yellow Card scheme. You do not need a clinician to do this; patients can submit reports themselves, and doing so helps build the safety picture for everyone on these medicines.
Persistent diarrhoea that does not settle after a few weeks raises a genuine clinical question: stay at 2.4mg and continue managing it, or discuss whether remaining at 1.7mg for longer might suit you better. This is not a failure. The move from 1.7mg to 2.4mg is the highest step in the schedule, and for some people the side-effect burden at the maximum dose outweighs the additional benefit.
That is exactly the kind of decision a prescriber should make with you, not one to arrive at alone based on how uncomfortable a few weeks have felt. At nume, every repeat order is clinically re-reviewed (no auto-renewals) so there is a natural point at which this conversation happens. If you are still on the 0.75mg dose and already noticing GI sensitivity, that is also worth raising with your prescriber before stepping up further. If diarrhoea is significantly affecting your daily life before that review, reach out rather than pushing through without support.
If you are still weighing up whether Wegovy at this dose is suitable for you at all, our prescribers discuss suitability and the full side-effect profile as a standard part of the consultation, you can check your eligibility and start a free consultation to explore that.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.